reviewBloodNov 28, 2016BRONZE OA

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

HDHartmut DöhnerEHElihu H. EsteyDGDavid GrimwadeSASergio AmadoriFRFrederick R. Appelbaum

Universität Ulm · Fred Hutch Cancer Center · +23 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

The first edition of the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults, published in 2010, has found broad acceptance by physicians and investigators caring for patients with AML. Recent advances, for example, in the discovery of the genomic landscape of the disease, in the development of assays for genetic testing and for detecting minimal residual disease (MRD), as well as in the development of novel antileukemic agents, prompted an international panel to provide updated evidence- and expert opinion-based recommendations. The recommendations include a revised version of the ELN genetic categories, a proposal for a response category based on…

Citation impact

5,846
total citations
FWCI
264.63
Percentile
100%
References
295
Citations per year

Authors

22

Topics & keywords

Topics
Keywords
  • Medicine
  • Expert opinion
  • Minimal residual disease
  • Genetic testing
  • Disease
  • Myeloid leukemia
  • Intensive care medicine
  • Oncology
No related works found for this paper.

Funding